Cite
HARVARD Citation
Uemura, H. et al. (2022). Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study. BJUI Compass. 3 (1), pp. 26-36. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Uemura, H. et al. (2022). Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study. BJUI Compass. 3 (1), pp. 26-36. [Online].